FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and medicine and concerns a pharmaceutical composition. The presented composition contains a recombinant lysozyme of FMV P. aeruginosa bacteriophage, ethylene diamine tetraacetate and TrisHCl in the following proportions, wt %: Lysozyme 0.001; TrisHCl 0.68; ethylene diamine tetraacetate 0.049; water - the rest.
EFFECT: characterised invention can be used for treating the infections caused by Pseudomonas aeruginosa and possesses immediate action and no side effects.
4 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BACTERIOPHAGE LYTIC ENZYME AND ANTIBACTERIAL COMPOSITION BASED THEREON | 2018 |
|
RU2703043C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730614C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730613C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST GRAM-NEGATIVE BACTERIA: PSEUDOMONAS AERUGINOSA, ACINETOBACTER BAUMANNII, KLEBSIELLA PNEUMONIAE AND SALMONELLA TYPHI (EMBODIMENTS) | 2019 |
|
RU2730615C1 |
| MODIFIED ENDOLYSIN AND ANTIBACTERIAL COMPOSITIONS BASED THEREON FOR TREATING INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII, PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI BACTERIA | 2023 |
|
RU2813626C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS AN ANTIMICROBIAL AGENT DIRECTED AGAINST ACINETOBACTER BAUMANNII BACTERIA, (EMBODIMENTS) | 2019 |
|
RU2730616C1 |
| BACTERIOPHAGES, PHAGE PEPTIDES AND METHODS FOR APPLICATION THEREOF | 2011 |
|
RU2614114C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE INFECTIONS CAUSED BY METICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCUS AUREUS, WHICH INCLUDES AS ACTIVE INGREDIENT N-TERMINAL CHAP-DOMAIN OF ENDOLYSIN OF BACTERIOPHAGE K STAPHYLOCOCCUS AUREUS | 2019 |
|
RU2715694C1 |
| ANTIBACTERIAL COMPOSITION BASED ON ENDOLYSINS AND DRUGS IN FORM OF GEL OR SPRAY, USING IT | 2021 |
|
RU2790481C1 |
| BACTERIOPHAGE POSSESSING ANTI-PSEUDOMONAS AERUGINOSA ACTIVITY, BACTERIOPHAGE PROTEINS AND METHODS FOR USING THEM | 2010 |
|
RU2580248C9 |
